From January 1, 2023 to March 31, 2023, the company has repurchased 5,200,000 shares, representing 7.97% for $55.1 million. With this, the company has completed the repurchase of 17,939,115 shares, representing 25.19% for $183.26 million under the buyback announced on September 19, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.7 USD | -0.80% | +1.99% | -22.60% |
23/05 | Transcript : Theravance Biopharma, Inc. - Special Call | |
13/05 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.60% | 423M | |
+48.39% | 779B | |
-6.13% | 354B | |
+20.61% | 333B | |
+10.00% | 301B | |
+18.87% | 249B | |
-1.96% | 216B | |
+11.11% | 214B | |
+5.80% | 163B | |
-2.50% | 159B |
- Stock Market
- Equities
- TBPH Stock
- News Theravance Biopharma, Inc.
- Tranche Update on Theravance Biopharma, Inc.'s Equity Buyback Plan announced on September 19, 2022.